139 related articles for article (PubMed ID: 32422075)
1. Leukocyte telomere length and
Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
[No Abstract] [Full Text] [Related]
2. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
[TBL] [Abstract][Full Text] [Related]
3. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
4. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N
PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
6. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
7. Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.
Kroupa M; Rachakonda S; Vymetalkova V; Tomasova K; Liska V; Vodenkova S; Cumova A; Rossnerova A; Vodickova L; Hemminki K; Soucek P; Kumar R; Vodicka P
Mutagenesis; 2020 Dec; 35(6):491-497. PubMed ID: 33367858
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte telomere length and renal cell carcinoma survival in two studies.
Callahan CL; Schwartz K; Ruterbusch JJ; Shuch B; Graubard BI; Lan Q; Cawthon R; Baccarelli AA; Chow WH; Rothman N; Hofmann JN; Purdue MP
Br J Cancer; 2017 Aug; 117(5):752-755. PubMed ID: 28742796
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
10. Association of Relative Leucocyte Telomere Length and Gene Single Nucleotide Polymorphisms (
Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
Cancer Genomics Proteomics; 2020; 17(4):431-439. PubMed ID: 32576588
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.
Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725
[TBL] [Abstract][Full Text] [Related]
13. Shorter Leukocyte Telomere Length coupled with lower expression of Telomerase Genes in patients with Essential Hypertension.
Cheng G; Wang L; Dai M; Wei F; Xu D
Int J Med Sci; 2020; 17(14):2180-2186. PubMed ID: 32922179
[No Abstract] [Full Text] [Related]
14. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease.
Zhang W; Chen Y; Yang X; Fan J; Mi X; Wang J; Zhang C; Hu FB; Hui R
PLoS One; 2012; 7(10):e47029. PubMed ID: 23082138
[TBL] [Abstract][Full Text] [Related]
15. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
16. Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.
Teixeira AL; Dias F; Ferreira M; Gomes M; Santos JI; Lobo F; Maurício J; Machado JC; Medeiros R
PLoS One; 2014; 10(4):e0103258. PubMed ID: 25909813
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
[TBL] [Abstract][Full Text] [Related]
18. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
Zhong W; Wang X; Pan B; Su Z
Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
[TBL] [Abstract][Full Text] [Related]
19. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
[TBL] [Abstract][Full Text] [Related]
20. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
